Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Anti-Inflammatory-Antioxidant Modifications and Synbiotics Improved Health-Related Conditions in Patients With Progressive Forms of Multiple Sclerosis: A Single-Center, Randomized Clinical Trial Publisher Pubmed



Moravejolahkami AR1 ; Chitsaz A2 ; Hassanzadeh A3 ; Paknahad Z1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Nutrition, School of Nutrition & Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Complementary Therapies in Clinical Practice Published:2023


Abstract

Background and purpose: There is growing evidence that dietary modification can improve clinical manifestations in multiple sclerosis (MS) patients. This study aimed to assess the impact of synbiotics and anti-inflammatory-antioxidant-rich diet on fatigue, pain, gut and bladder status, and sexual function in patients with progressive forms of MS. Materials and methods: In this single-center, single-blind, randomized, controlled clinical trial, seventy participants with three forms of progressive MS (primary-progressive, secondary-progressive, and progressive-relapsing) were randomly assigned to receive either synbiotics supplement and anti-inflammatory-antioxidant-rich diet or a placebo along with their usual diet for a duration of four months. Modified fatigue impact scale (MFIS), global pain scale (GPS), bladder control scale (BLCS), bowel control scale (BWCS), and sexual satisfaction scale (SSS) were assessed at baseline and at the end of the trial. Results: Sixty-nine participants successfully completed the trial, resulting in a 98% adherence rate to the diet, and no reports of serious side effects. Significant mean changes were observed in fatigue (Δ for experimental group = −10.5 ± 10.8 vs. Δ for control group = −0.08 ± 4.1; P < 0.001), pain (−14.1 ± 19.0 vs. 0.9 ± 10.3; P < 0.001), bladder (−0.76 ± 2.1 vs. 0.3 ± 1.1; P = 0.013) and bowel (−6.6 ± 3.2 vs. −0.05 ± 2.3; P < 0.001) control, as well as sexual function (−1.0 ± 2.3 vs. 0.51 ± 0.21; P < 0.001). Conclusion: The anti-inflammatory-antioxidant-rich diet and synbiotics co-supplementation demonstrated improvements in fatigue, pain, sexual function, and bowel/bladder status among patients with progressive MS. © 2023 Elsevier Ltd
Related Docs
View other Related Docs
1. Effects of Anti-Inflammatory-Antioxidant-Rich Diet and Co-Supplemented Synbiotics Intervention in Patients With Progressive Forms of Multiple Sclerosis: A Single-Center, Single-Blind Randomized Clinical Trial, Nutritional Neuroscience (2023)
2. Co-Supplementation of Synbiotics and Anti-Inflammatory-Antioxidant Rich Diet in Patients With Progressive Forms of Multiple Sclerosis: A Single-Center, Randomized Clinical Trial, Mediterranean Journal of Nutrition and Metabolism (2024)
3. Effect of Mediterranean Diet on Body Mass Index and Fatigue Severity in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis of Clinical Trials, Heliyon (2024)
4. A Mediterranean-Type Diet Improved Systemic Inflammation in Multiple Sclerosis Patients, As Compared to the Traditional Iranian Diet: A Single-Center Randomized Controlled Trial, Mediterranean Journal of Nutrition and Metabolism (2021)
5. Modified Mediterranean Diet V. Traditional Iranian Diet: Efficacy of Dietary Interventions on Dietary Inflammatory Index Score, Fatigue Severity and Disability in Multiple Sclerosis Patients, British Journal of Nutrition (2022)
6. Potential of Modified Mediterranean Diet to Improve Quality of Life and Fatigue Severity in Multiple Sclerosis Patients: A Single-Center Randomized Controlled Trial, International Journal of Food Properties (2020)
7. Association of Dietary Patterns With Systemic Inflammation, Quality of Life, Disease Severity, Relapse Rate, Severity of Fatigue and Anthropometric Measurements in Ms Patients, Nutritional Neuroscience (2020)
8. Effect of Synbiotics on Inflammatory Markers and White Blood Cell Count in Covid-19 Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Nutrition and Food Science (2023)
Experts (# of related papers)
View all Related Experts
Vahid Shaygannejad (39)
Fereshteh Ashtari (18)
Other Related Docs
9. Effect of Probiotics Supplementation on Disease Progression, Depression, General Health, and Anthropometric Measurements in Relapsing-Remitting Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis of Clinical Trials, International Journal of Clinical Practice (2021)
10. Probiotics, Prebiotics, and Synbiotics in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Clinical Trials, Diabetes/Metabolism Research and Reviews (2024)
11. Sexual Dysfunction in Women With Multiple Sclerosis: Prevalence and Impact on Quality of Life, BMC Urology (2020)
12. Association of Polyunsaturated Fatty Acid Intake on Inflammatory Gene Expression and Multiple Sclerosis: A Systematic Review and Meta-Analysis, Nutrients (2022)
13. The Effects of Different Kinds of Nutrition and Functional Foods on Multiple Sclerosis, Current Nutrition and Food Science (2020)
14. Investigation of the Effects of Cocoa Powder on Fatigue Severity in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Controlled Trial, Clinical Nutrition Open Science (2024)
15. Dietary Intake of Energy and Fiber in Ms Patients; an Approach to Prebiotics Role, Nutrition and Food Science (2019)
16. Sexual Dysfunction in Women With Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis, Sexuality and Disability (2022)
17. Comparison of the Impact of Intermittent Fasting Diet Alone or in Conjunction With Probiotic Supplementation Versus Calorie-Restricted Diet on Inflammatory, Oxidative Stress, and Antioxidant Capacity Biomarkers in Women With Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Trial, Journal of Research in Medical Sciences (2025)
18. Dietary Inflammatory Index and Risk of Multiple Sclerosis: Findings From a Large Population-Based Incident Case–Control Study, Clinical Nutrition (2020)
19. Impact of the Covid-19 Pandemic on the Psychological Status and Cortisol Level of Multiple Sclerosis Patients, Neuropsychological Rehabilitation (2023)
20. Association Between Dietary Inflammatory Index and Risk of Demyelinating Autoimmune Diseases: A Cross-Sectional Study, International Journal for Vitamin and Nutrition Research (2024)
21. Evaluating the Effect of Adding Fish Oil to Fingolimod on Tnf-Α Il1β Il6, and Ifn-Γ in Patients With Relapsing-Remitting Multiple Sclerosis: A Double-Blind Randomized Placebo-Controlled Trial, Clinical Neurology and Neurosurgery (2017)
22. The Prevalence of Lower Urinary Tract Symptoms Based on Individual and Clinical Parameters in Patients With Multiple Sclerosis, BMC Neurology (2020)
23. Multiple Sclerosis-Related Fatigue Lacks a Unified Definition: A Narrative Review, Journal of Research in Medical Sciences (2022)
24. Does Lipoic Acid Consumption Affect the Cytokine Profile in Multiple Sclerosis Patients: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial, NeuroImmunoModulation (2014)
25. The Efficacy of Probiotics on Virus Titres and Antibody Production in Virus Diseases: A Systematic Review on Recent Evidence for Covid-19 Treatment, Clinical Nutrition ESPEN (2021)
26. Ginseng in the Treatment of Fatigue in Multiple Sclerosis: A Randomized, Placebo-Controlled, Double-Blind Pilot Study, International Journal of Neuroscience (2013)
27. Several Food Items and Multiple Sclerosis: A Case-Control Study in Ahvaz (Iran), Iranian Journal of Nursing and Midwifery Research (2014)
28. Effectiveness of Bupropion on Sexual Dysfunction of Women With Multiple Sclerosis: A Clinical Trial, Iranian Journal of Obstetrics, Gynecology and Infertility (2021)
29. Effects of Prolonged Fasting on Fatigue and Quality of Life in Patients With Multiple Sclerosis, Neurological Sciences (2016)
30. Islamic Fasting and Multiple Sclerosis, BMC Neurology (2014)
31. The Effect of Ginger (Zingiber Officinale) Supplementation on Clinical, Biochemical, and Anthropometric Parameters in Patients With Multiple Sclerosis: A Double-Blind Randomized Controlled Trial, Food and Function (2023)
32. The Role of Nutritional Factors During Adolescence in Multiple Sclerosis Onset: A Population-Based Incident Case–Control Study, Nutritional Neuroscience (2021)
33. Effect of Synbiotics and Probiotics Supplementation on Autoimmune Diseases: A Systematic Review and Meta-Analysis of Clinical Trials, Clinical Nutrition (2021)
34. The Role of Cobalamin in Multiple Sclerosis: An Update, Inflammation (2024)
35. Appetite Sensation Improvement by Synbiotic Supplementation in Patients With Metabolic Syndrome: A Randomized Controlled Clinical Trial, Food Science and Nutrition (2024)
36. Serum Uric Acid Level in Patients With Relapsing-Remitting Multiple Sclerosis, Journal of Clinical Neuroscience (2013)
37. Comparison of the Effect of Aspirin and Amantadine for the Treatment of Fatigue in Multiple Sclerosis: A Randomized, Blinded, Crossover Study, Neurological Research (2012)
38. Th1, Th2 and Th17 Cytokine Profile in Patients With Multiple Sclerosis Following Treatment With Rapamycin, Iranian Journal of Immunology (2016)
39. Comparative Study of Quality of Life, Anxiety, Depression, and Fatigue Among Patients With Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: The First Report From Iran, Multiple Sclerosis and Related Disorders (2018)
40. Stability of Mental Toughness, Sleep Disturbances, and Physical Activity in Patients With Multiple Sclerosis (Ms)-A Longitudinal and Pilot Study, Frontiers in Psychiatry (2018)
41. Effectiveness of Multiple Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis: Causal Inference to Emulate a Multiarm Randomised Trial, Journal of Neurology, Neurosurgery and Psychiatry (2023)
42. The Beneficial Effects of Vitamin D3 on Reducing Antibody Titers Against Epstein-Barr Virus in Multiple Sclerosis Patients, Cellular Immunology (2015)
43. Assessment of Intelligence Quotient in Patients With Neuromyelitis Optica Spectrum Disease and Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)
44. Association of Helicobacter Pylori With Multiple Sclerosis: Protective or Risk Factor?, Current Journal of Neurology (2020)
45. Male Sex Is Independently Associated With Faster Disability Accumulation in Relapse-Onset Ms But Not in Primary Progressive Ms, PLoS ONE (2015)
46. Effects of Spirulina Supplementation in Patients With Ulcerative Colitis: A Double-Blind, Placebo-Controlled Randomized Trial, BMC Complementary Medicine and Therapies (2024)
47. Serum Lipids and Cognitive Outcomes in Multiple Sclerosis; a Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2024)
48. Prevalence and Risk Factors of Dysphagia in Patients With Multiple Sclerosis, Dysphagia (2022)
49. Fatigue, Depression, and Health-Related Quality of Life in Patients With Multiple Sclerosis in Isfahan, Iran, European Journal of Neurology (2012)
50. Short Report: Assessment of Coping Strategies in Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd) and Multiple Sclerosis, Psychology, Health and Medicine (2022)